- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 24, 2021
Finance
With cancer foot forward, Step making strides toward clinic with €35M series B
French biotech considering accelerated pathway for lead program
BioCentury | Oct 19, 2020
Finance
How Nimbus’ focus on internal pipeline could point to long-awaited exit
BioCentury | Feb 16, 2017
Emerging Company Profile
Autoimmunity alternative
Why Step Pharma thinks CTPS1 could become a hot autoimmune target
BioCentury | Jan 19, 2017
Finance
Kurma chameleon
How French VC Kurma is bringing industry into tech transfer before creating newcos
Items per page:
1 - 6 of 6